Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
In pancreatic cancer, the epigenomic landscape can strongly impact the disease phenotype. Here, the authors discuss recent advances in our understanding of pancreatic cancer epigenomics, and how this knowledge can integrate with precision medicine approaches in this lethal disease.
Guardado en:
Autores principales: | Gwen Lomberk, Nelson Dusetti, Juan Iovanna, Raul Urrutia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0784c10024e34076bcbf2a0a39e6dc2f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
por: Gwen Lomberk, et al.
Publicado: (2018) -
Collateral Victim or Rescue Worker?—The Role of Histone Methyltransferases in DNA Damage Repair and Their Targeting for Therapeutic Opportunities in Cancer
por: Lishu He, et al.
Publicado: (2021) -
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Federica Vernuccio, et al.
Publicado: (2021) -
Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
por: Feng Liu, et al.
Publicado: (2017) -
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine
por: Zi‐Hang Chen, et al.
Publicado: (2021)